About
We aim to develop the next generation of enzyme-based treatments for various diseases. Our innovations include improving both the upstream molecules and the downstream manufacturing process. On the downstream side, we are developing a novel chromatography purification device that is capable of purifying commercial quantities of biological drugs in an easy-to-use and cost-effective way. This "plug-and-play" concept device also utilizes a unique simulation software which takes advantage of computational power in order to make process development much simpler and more effective than the traditional approach. Innovations at upstream and downstream areas will make medical treatments more effective and accessible. Our vision is to decrease the "burden of treatment" on patients - financially, physically, and mentally. This is especially critical for enzyme-based therapies because patients would normally need to follow such treatments for a lifetime.